Incyte misses quarterly profit on weak sales of lead drug saltwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltwire.com Daily Mail and Mail on Sunday newspapers.
Incyte Corp on Tuesday
reported fourth-quarter profit below Wall Street estimates, hit
by higher costs related to its products such as skin disorder
drug Opzelura and forecast weak sales for its lead.